The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
122347404 12234740 4 F 20160915 20160404 20160927 EXP JP-JNJFOC-20160400393 JANSSEN NAKAYAMA S, SUZUKI Y, MIZUTANI Y, HIRAMOTO N, TANAKA J, HANDA M, ET AL. PP427: A CASE OF ACUTE RESPIRATORY DISTRESS SYNDROME DURING TREATMENT OF MALIGNANT LYMPHOMA WITH RHEUMATOID ARTHRITIS. ANNALS OF THE JAPANESE RESPIRATORY SOCIETY 2016;5:248. YOSHIZAWA T. P-237: A CASE OF TOKO-TSUBO CARDIOMYOPATHY COMPLICATING CORONARY SPASTIC ANGINA DURING TREATMENT FOT MALT LYMPHOMA. THE 64TH ANNUAL SCIENTIFIC SESSION OF THE JAPANESE COLLEGE OF CARDIOLOGY SEP-2016. 76.00 YR E F Y 0.00000 20160927 OT JP JP

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
122347404 12234740 1 PS REMICADE INFLIXIMAB 1 Intravenous (not otherwise specified) D N 103772 LYOPHILIZED POWDER
122347404 12234740 2 SS DOXORUBICIN HYDROCHLORIDE. DOXORUBICIN HYDROCHLORIDE 1 Unknown D 0 UNKNOWN
122347404 12234740 3 SS METHOTREXATE. METHOTREXATE 1 Unknown 0 UNSPECIFIED
122347404 12234740 4 SS RITUXIMAB RITUXIMAB 1 Unknown D 0 UNSPECIFIED
122347404 12234740 5 SS CYCLOPHOSPHAMIDE. CYCLOPHOSPHAMIDE 1 Unknown D 0 UNSPECIFIED
122347404 12234740 6 SS VINCRISTINE SULFATE. VINCRISTINE SULFATE 1 Unknown D 0 UNSPECIFIED
122347404 12234740 7 SS PREDNISOLONE. PREDNISOLONE 1 Unknown U 0 UNSPECIFIED

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
122347404 12234740 1 Rheumatoid arthritis
122347404 12234740 2 Extranodal marginal zone B-cell lymphoma (MALT type)
122347404 12234740 3 Rheumatoid arthritis
122347404 12234740 4 Extranodal marginal zone B-cell lymphoma (MALT type)
122347404 12234740 5 Extranodal marginal zone B-cell lymphoma (MALT type)
122347404 12234740 6 Extranodal marginal zone B-cell lymphoma (MALT type)
122347404 12234740 7 Extranodal marginal zone B-cell lymphoma (MALT type)

Outcome of event

Event ID CASEID OUTC COD
122347404 12234740 DE

Reactions reported

Event ID CASEID DRUG REC ACT PT
122347404 12234740 Acute respiratory distress syndrome
122347404 12234740 Extranodal marginal zone B-cell lymphoma (MALT type)
122347404 12234740 Infection
122347404 12234740 Prinzmetal angina
122347404 12234740 Respiratory failure
122347404 12234740 Stress cardiomyopathy

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

no results found